Yellow Plaque on Skin (Xanthoma)

What is Yellow plaque on skin (Xanthoma)?

A xanthoma is a benign, yellow‑to‑orange colored plaque, nodule, or papule that appears on the skin or tendons. These lesions are composed of lipid‑laden (fat‑filled) macrophages, known as foam cells, that accumulate in the dermis when there is an excess of circulating lipids (cholesterol, triglycerides, or other fats). Although the lesions themselves are not cancerous, they are an important visual clue that an underlying metabolic or systemic disorder may be present.

Xanthomas can vary in size from a few millimeters to several centimeters and may appear as a solitary plaque or in clusters. They are most commonly found on the eyelids (xanthelasma), elbows, knees, hands, buttocks, and the tendons of the hands and feet, but they can develop anywhere on the body.

Common Causes

The appearance of xanthomas usually signals a disturbance in lipid metabolism. Below are the most frequently encountered conditions that can produce yellow plaques:

• Familial hypercholesterolemia (FH) – an inherited defect in LDL‑receptor function causing markedly elevated LDL cholesterol.
• Familial combined hyperlipidemia – high levels of LDL, VLDL, and triglycerides.
• Type IIb hyperlipoproteinemia – elevated LDL and VLDL.
• Type III hyperlipoproteinemia (Dysbetalipoproteinemia) – abnormal apoE leading to accumulation of remnants rich in cholesterol.
• Type IV hyperlipoproteinemia – high triglycerides (VLDL excess) often associated with pancreatitis.
• Secondary hyperlipidemia due to uncontrolled diabetes mellitus, hypothyroidism, nephrotic syndrome, or chronic liver disease.
• Drug‑induced lipid disturbances – e.g., isotretinoin, bicalutamide, or high‑dose corticosteroids.
• Gaucher disease – a lysosomal storage disorder that can cause “crenated” xanthomas on the hands.
• Arcus senilis – while not a plaque, the presence of a cholesterol ring around the cornea often co‑exists with xanthomas in severe hypercholesterolemia.
• Other rare causes – such as cholestatic liver disease, certain malignancies (e.g., multiple myeloma), and chronic granulomatous disease.

Associated Symptoms

Xanthomas rarely cause pain or itching, but they may be accompanied by other signs that point to the underlying disorder:

• Fatigue, weakness, or unexplained weight loss (common in uncontrolled diabetes or hyperthyroidism).
• History of premature cardiovascular disease – heart attack, angina, or stroke before age 55 (men) / 65 (women).
• Abdominal pain or pancreatitis (especially with very high triglycerides).
• Swelling of the legs or facial edema in nephrotic syndrome.
• Yellowing of the eyes (xanthelasma) that may precede systemic xanthomas.
• Joint pain or swelling if tendinous xanthomas are large enough to interfere with movement.
• Skin changes such as eruptive xanthomas (tiny yellow papules) on the trunk and buttocks, indicating severe hypertriglyceridemia.

When to See a Doctor

Because xanthomas can be the first visible sign of serious lipid disorders, prompt evaluation is important. Seek medical care if you notice:

• Sudden appearance of a yellow plaque that is larger than a pea.
• Multiple or spreading lesions, especially on the elbows, knees, or hands.
• Any personal or family history of high cholesterol, early heart disease, or stroke.
• Associated symptoms such as chest pain, shortness of breath, or sudden severe abdominal pain (possible pancreatitis).
• Rapid growth of a plaque that becomes painful, ulcerated, or infected.
• Signs of a systemic illness—unexplained weight loss, night sweats, fever, or persistent fatigue.

Diagnosis

The evaluation of a suspected xanthoma involves both a visual assessment and laboratory testing.

Clinical examination

• Dermatologic inspection – noting size, number, distribution, and texture.
• Palpation – most xanthomas are soft to firm but not tender.
• Assessment for tendon involvement – tendinous xanthomas feel rubbery and are often found over the Achilles or extensor tendons.

Laboratory studies

• Lipid profile – total cholesterol, LDL‑C, HDL‑C, triglycerides, and VLDL.
• Blood glucose and HbA1c to identify diabetes‑related dyslipidemia.
• Thyroid‑stimulating hormone (TSH) and free T4 – to rule out hypothyroidism.
• Kidney function tests (creatinine, urine protein) – assess for nephrotic syndrome.
• Liver function tests – especially if cholestatic disease is suspected.
• Genetic testing (e.g., LDLR, APOB, PCSK9) when familial hypercholesterolemia is considered.

Imaging & procedures

• Dermatoscopy – helps differentiate xanthoma from other yellowish lesions (e.g., syringomas, sebaceous hyperplasia).
• Skin biopsy – rarely needed but may be performed if the diagnosis is uncertain; histology shows foamy macrophages in the dermis.
• Cardiovascular risk assessment – carotid ultrasound, coronary calcium scoring, or stress testing if high‑risk lipids are documented.

Treatment Options

Because xanthomas are a manifestation of an underlying lipid disorder, the cornerstone of therapy is correcting the lipid abnormality.

Medical management

• Statins (e.g., atorvastatin, rosuvastatin) – first‑line agents to lower LDL‑C; they can shrink or resolve many xanthomas over months to years.
• Ezetimibe – added when statins alone are insufficient.
• PCSK9 inhibitors (evolocumab, alirocumab) – highly effective for familial hypercholesterolemia when statins are inadequate.
• Fibrates (gemfibrozil, fenofibrate) – primarily reduce triglycerides; useful for eruptive xanthomas linked to hypertriglyceridemia.
• Niacin – can raise HDL‑C and lower triglycerides, but side‑effects limit use.
• Omega‑3 fatty acid supplements – EPA/DHA can lower triglycerides.
• Management of secondary causes – optimizing diabetes control, treating hypothyroidism, or using immunosuppressive therapy for nephrotic syndrome.

Procedural & cosmetic options

• Laser therapy (e.g., CO₂ or pulsed dye laser) – useful for small, superficial xanthomas, particularly on the face.
• Surgical excision – considered for large or symptomatic tendinous xanthomas, especially when they impede movement.
• Cryotherapy – occasionally employed for eruptive lesions.
• Topical retinoids – have limited benefit; mainly used for cosmetic smoothing.

Lifestyle measures

• Adopt a heart‑healthy diet – emphasize fruits, vegetables, whole grains, lean protein, and limit saturated/trans fats and simple sugars.
• Increase physical activity – at least 150 minutes of moderate‑intensity aerobic exercise per week.
• Weight management – reducing excess weight improves triglyceride levels.
• Avoid tobacco and limit alcohol, both of which can raise triglycerides.

Prevention Tips

While you cannot always prevent xanthomas—especially those caused by genetic lipid disorders—several steps can reduce the risk of development or recurrence:

• Screen family members if you have a known inherited lipid condition; early identification allows treatment before lesions appear.
• Maintain regular lipid panel testing (at least every 3–5 years for adults without known risk, annually if you have a risk factor).
• Control blood sugar and blood pressure; both influence lipid metabolism.
• Follow prescribed lipid‑lowering medication regimens even if lesions have already faded; stopping therapy may cause recurrence.
• Stay hydrated and limit high‑fructose corn syrup intake, which can exacerbate triglyceride spikes.
• Educate yourself on medication side‑effects—some drugs raise lipids; discuss alternatives with your physician.

Emergency Warning Signs

Key Take‑aways

Yellow plaques known as xanthomas are visual markers of lipid imbalance that can herald serious cardiovascular or metabolic disease. Early recognition, thorough laboratory work‑up, and aggressive lipid‑lowering therapy are essential to shrink existing lesions and prevent complications such as heart attack, stroke, and pancreatitis. Lifestyle modification complements medication, and regular follow‑up with a healthcare professional ensures that both the skin findings and the underlying disorder remain under control.

Sources: Mayo Clinic. “Xanthomas.”; American Heart Association. “Lipid Disorders.”; National Institutes of Health (NIH) – National Lipid Association; Centers for Disease Control and Prevention (CDC) – “High Blood Cholesterol.”; Cleveland Clinic – “Familial Hypercholesterolemia.”; Journal of the American College of Cardiology 2023; WHO. “Non‑communicable diseases fact sheet.”